Loading…
A novel use of an Amplatzer septal occluder
[...]we felt that her clinical condition was compromised by the persistent patency of the modified Blalock Taussig shunt. [...]on the first day after the operation, percutaneous occlusion was attempted in the catheter laboratory using an 8 mm Cook coil introduced via the right femoral artery. In the...
Saved in:
Published in: | Heart (British Cardiac Society) 1999-06, Vol.81 (6), p.672-673 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]we felt that her clinical condition was compromised by the persistent patency of the modified Blalock Taussig shunt. [...]on the first day after the operation, percutaneous occlusion was attempted in the catheter laboratory using an 8 mm Cook coil introduced via the right femoral artery. In the catheter laboratory, a 4 mm Amplatzer septal occluder (AGA Medical Corporation, Minnesota, USA) was placed in the patent shunt via the left femoral vein, right atrial tunnel, and right pulmonary artery. |
---|---|
ISSN: | 1355-6037 1468-201X |
DOI: | 10.1136/hrt.81.6.672 |